[{"NetIncomeLoss_1_Q2_USD":-21101000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":6257000.0,"InterestPaidNet_2_Q2_USD":1309000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":33512000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"AccountsPayableRelatedPartiesCurrent_0_Q2_USD":142000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-733000.0,"Depreciation_2_Q2_USD":129000.0,"Depreciation_1_Q2_USD":77000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":276727.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":516000.0,"AssetsCurrent_0_Q2_USD":248679000.0,"OperatingLeaseExpense_2_Q2_USD":200000.0,"OperatingLeaseExpense_1_Q2_USD":100000.0,"LongTermDebt_0_Q2_USD":46259000.0,"LongTermDebtCurrent_0_Q2_USD":1389000.0,"DebtInstrumentUnamortizedDiscount_0_Q2_USD":3741000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":25000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":503000.0,"CommonStockSharesIssued_0_Q2_shares":28964506.0,"Assets_0_Q2_USD":252422000.0,"ShareBasedCompensation_2_Q2_USD":1391000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2614000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":13423199.0,"InterestExpenseRelatedParty_2_Q2_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":32997099.0,"InterestExpenseRelatedParty_1_Q2_USD":0.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":32733750.0,"GeneralAndAdministrativeExpense_2_Q2_USD":9672000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":200000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":30724000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":14859000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":12.93,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":2568000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-1000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.6372,"CommonStockValue_0_Q2_USD":3000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":8129000.0,"InterestPayableCurrent_0_Q2_USD":302000.0,"PropertyPlantAndEquipmentDisposals_2_Q2_USD":0.0,"DepreciationDepletionAndAmortization_2_Q2_USD":129000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":25000000.0,"FairValueAdjustmentOfWarrants_2_Q2_USD":-95000.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_2_Q2_USD":0.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":1510000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0082,"OtherAssetsNoncurrent_0_Q2_USD":381000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":247271000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1746000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":486081000.0,"Liabilities_0_Q2_USD":63999000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q2_shares":3350094.0,"OperatingLeaseLiability_0_Q2_USD":2162000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5162000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":406000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":529000.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"AmortizationOfFinancingCosts_2_Q2_USD":544000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":137000.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_2_Q2_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":828000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-20761000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":490000.0,"LiabilitiesCurrent_0_Q2_USD":13258000.0,"AccountsPayableCurrent_0_Q2_USD":4894000.0,"NonoperatingIncomeExpense_2_Q2_USD":-846000.0,"NonoperatingIncomeExpense_1_Q2_USD":-1080000.0,"InterestExpense_2_Q2_USD":2000000.0,"InterestExpense_1_Q2_USD":1262000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1408000.0,"LongTermDebtNoncurrent_0_Q2_USD":44870000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0725,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":247271000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_2_Q2_USD":0.0,"OperatingLeasePayments_2_Q2_USD":700000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":20000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":748000.0,"NetIncomeLoss_2_Q2_USD":-41242000.0,"CommonStockSharesOutstanding_0_Q2_shares":25614412.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":3506000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-297661000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":1677255.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-10428000.0,"CommonStockSharesAuthorized_0_Q2_shares":400000000.0,"OperatingIncomeLoss_2_Q2_USD":-40396000.0,"OperatingIncomeLoss_1_Q2_USD":-20021000.0,"IncreaseDecreaseInInterestPayableNet_2_Q2_USD":146000.0,"InvestmentIncomeInterest_2_Q2_USD":1060000.0,"InvestmentIncomeInterest_1_Q2_USD":182000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":32.34,"LiabilitiesAndStockholdersEquity_0_Q2_USD":252422000.0,"PreferredStockSharesAuthorized_0_Q2_shares":40000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1391000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":188000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":828000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":10600000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":885000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":416000.0,"OperatingExpenses_2_Q2_USD":40396000.0,"OperatingExpenses_1_Q2_USD":20021000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.26,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.64,"ProfitLoss_2_Q2_USD":-41242000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":4125000.0,"StockholdersEquity_0_Q2_USD":188423000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":733000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":50000000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardGross_1_Q2_USD":1000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":211000.0,"Ticker":"PHAT","CIK":"1783183","name":"PHATHOM PHARMACEUTICALS, INC.","OfficialName":"Phathom Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"562637189.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]